טוען...
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
Ovarian cancer patients with homologous recombination deficiencies exhibit specific clinical behaviors, and improved responses to treatments, such as platinum-based chemotherapy and poly (ADP-ribose) polymerase (PARP) inhibitors, have been observed. Germline mutations in the BRCA 1/2 genes are the m...
שמור ב:
| הוצא לאור ב: | Clinics (Sao Paulo) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096977/ https://ncbi.nlm.nih.gov/pubmed/30133561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2018/e450s |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|